Petra Pharma focuses on developing small molecules that target important cellular processes like cell division, growth, trafficking, and signaling. Their therapies modulate phosphoinositide (PI) signaling pathways to treat cancer and metabolic diseases. Founded in 2016 and headquartered in New York, Petra Pharma aims to provide doctors with access to innovative drugs for the treatment of their patients.